|
US2019337898A1
|
|
Multi-tyrosine kinase inhibitors derivatives and methods of use
|
|
US10464902B1
|
|
Multi-tyrosine kinase inhibitors derivatives and methods of use
|
|
US2018009758A1
|
|
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
US2017342033A1
|
|
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
US2017143688A1
|
|
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
US2017112821A1
|
|
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
US2017020856A1
|
|
N-Acylalkyl Prodrugs of Multi-Tyrosine Kinase Inhibitors and Methods of Use
|
|
US2016376239A1
|
|
N-Acylalkyl Prodrugs of Multi-Tyrosine Kinase Inhibitors and Methods of Use
|
|
EP3094284A2
|
|
Compositions and methods for the treatment of intraocular neovascularization and/or leakage
|
